Artificial Intelligence (AI) In Respiratory Diseases Market Outlook 2024-2033: Trends and Projections

The artificial intelligence (ai) in respiratory diseases global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Artificial Intelligence (AI) In Respiratory Diseases Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The AI in respiratory diseases market size has grown strongly in recent years. It will grow from $7.25 billion in 2023 to $7.66 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing government regulations, growing environmental concerns, increasing aging population, growing patient-centric healthcare approaches, rise in healthcare infrastructure development.

The AI in respiratory diseases market size is expected to see steady growth in the next few years. It will grow to $9.35 billion in 2028 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising need for early detection and diagnosis, growing environmental pollution, rising healthcare expenditure, research and development initiatives. Major trends in the forecast period include technological advancements, drug discovery and development, personalized treatment plans, telemedicine and remote patient monitoring, remote patient monitoring.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Scope Of Artificial Intelligence (AI) In Respiratory Diseases Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Artificial Intelligence (AI) In Respiratory Diseases Market Overview

Market Drivers –
Growing environmental pollution is expected to propel the growth of artificial intelligence (AI) in the respiratory disease market going forward. Environmental pollution refers to the addition of any substance or form of energy to the environment at a rate faster than it can be dispersed or stored in a harmless form. AI in respiratory diseases has the potential to significantly reduce the impact of environmental pollution on respiratory health by offering real-time monitoring, personalized risk assessments, informed decision-making, and innovative solutions for both individuals and communities. For instance, in November 2023, according to the United States Environmental Protection Agency, a US-based government agency, in the US around 66 million tons of pollution was emitted into the atmosphere in 2022. Further, US greenhouse gas emissions by the economic sector increased by 6,025.97 million metric tons (MMT) of CO2 in 2020 to 6,340.23 million metric tons (MMT) of CO2 in 2021. Therefore, growing environmental pollution is driving the growth of artificial intelligence (AI) in the respiratory disease market.

Market Trends –
Major companies operating in artificial intelligence (AI) in the respiratory diseases market are developing innovative products such as N-Tidal devices to monitor patients’ tidal breathing. The n-Tidal device measures the volume of air exchanged during normal breathing and provides valuable information about lung function. For instance, in August 2023, TidalSense, a UK-based respiratory technology company, launched N-Tidal, a regulated AI technology for chronic obstructive pulmonary disease (COPD) diagnosis and management. The technology combines N-Tidal’s CO2 sensor data with an artificial intelligence platform to measure changes in lung function, aiming to improve the diagnosis and management of this respiratory condition. Clinical studies have demonstrated the technology’s high accuracy, and it is expected to reform the diagnostic process for respiratory diseases. The launch is a significant development in the use of AI for respiratory disease assessment, offering a more comfortable and efficient alternative to existing diagnostic tests.

The artificial intelligence (ai) in respiratory diseases market covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Get an inside scoop of the artificial intelligence (ai) in respiratory diseases market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

Regional Insights –
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ , Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.

Table of Contents
1. Executive Summary
2. Artificial Intelligence (AI) In Respiratory Diseases Market Report Structure
3. Artificial Intelligence (AI) In Respiratory Diseases Market Trends And Strategies
4. Artificial Intelligence (AI) In Respiratory Diseases Market – Macro Economic Scenario
5. Artificial Intelligence (AI) In Respiratory Diseases Market Size And Growth
…..
27. Artificial Intelligence (AI) In Respiratory Diseases Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model